This information is about how the weight loss drug tirzepatide (Mounjaro®) will be prescribed to patients.
The local NHS is aiming for this drug to be available to those eligible later in the year but is paused whilst we set up local clinics for Derby and Derbyshire.
We are working across the local NHS to put in place community-based clinics to meet areas of greatest need.
This is being organised by the Integrated Care Board (ICB) which has the responsibility
Who can get these injections
There are clear rules about which patients can get tirzepatide (Mounjaro®) from primary care.
Eligible groups will be phased, the initial priority criteria are as follows:
You must have a BMI (Body Mass Index) of 40 plus* and four or more of the following diagnosed health conditions:
✓ type 2 diabetes
✓ high blood pressure
✓ heart disease
✓ obstructive sleep apnoea
✓ abnormal blood fats (dyslipidaemia)
(* We use a lower BMI threshold – usually reduced by 2.5 kg/m2 – for people from South Asian, Chinese, other Asian, Middle Eastern, Black African or African-Caribbean ethnic backgrounds.)
Website: Tirzepatide » Joined Up Care Derbyshire
